Yanan Zhu
Stock Analyst at Wells Fargo
(1.41)
Main Sectors:
Top Industries:
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
MGX Metagenomi | Maintains: Overweight | 16 12 | 1.81 | 562.98% | 4 | Aug 14, 2025 | |
TSHA Taysha Gene Therapie... | Maintains: Overweight | 8 8 | 2.75 | 190.91% | 3 | Aug 13, 2025 | |
FATE Fate Therapeutics | Maintains: Equal-Weight | 4 3 | 0.94 | 165.96% | 4 | Aug 13, 2025 | |
AUTL Autolus Therapeutics | Maintains: Overweight | 6 5 | 2.46 | 103.25% | 4 | Aug 13, 2025 | |
ARCT Arcturus Therapeutic... | Maintains: Overweight | 45 42 | 11.39 | 268.74% | 8 | Aug 12, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 51 38 | 9.45 | 302.12% | 5 | Aug 8, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 18 14 | 1.97 | 610.66% | 5 | Aug 8, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 50 45 | 10.75 | 318.6% | 5 | Aug 8, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 70 75 | 45.74 | 63.97% | 4 | Aug 8, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 48 50 | 17.95 | 178.55% | 6 | Aug 7, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 2 1 | n/a | n/a | 3 | May 14, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | 11 1 | n/a | n/a | 7 | May 13, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 75 70 | 17.16 | 307.93% | 3 | May 7, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | 9 | 8.16 | 10.29% | 2 | May 1, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 12 10 | 3.08 | 224.68% | 2 | Mar 12, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 35 30 | 14.13 | 112.31% | 2 | Feb 28, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 40 5 | 4.97 | 0.6% | 8 | Feb 24, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | 7 4 | 2.2 | 81.82% | 6 | Dec 11, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 82 77 | 40.84 | 88.54% | 2 | Nov 7, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 35 40 | 15.22 | 162.81% | 2 | May 13, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 70 65 | 55.44 | 17.24% | 1 | May 9, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 30 | 3.71 | 708.63% | 1 | Apr 22, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | 10 | 10.25 | -2.44% | 2 | Dec 27, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 9 13 | 12.01 | 4.08% | 3 | Aug 16, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 5 4 | n/a | n/a | 3 | Aug 10, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 30 24 | 1.4 | 1614.29% | 1 | Jul 13, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Overweight | 450 | 2.63 | 17010.27% | 1 | Mar 27, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 1 1 | n/a | n/a | 2 | Oct 25, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 272 326 | 638.76 | -48.96% | 1 | Feb 2, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 79 70 | 51.99 | 34.64% | 2 | Oct 29, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | 48 53 | n/a | n/a | 2 | Aug 19, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 122 133 | n/a | n/a | 4 | May 7, 2020 |